Genprex Revenue and Competitors

Austin, TX USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Genprex's estimated annual revenue is currently $5.4M per year.(i)
  • Genprex's estimated revenue per employee is $155,000

Employee Data

  • Genprex has 35 Employees.(i)
  • Genprex grew their employee count by 13% last year.

Genprex's People

NameTitleEmail/Phone
1
Chairman the Board, President, CEOReveal Email/Phone
2
SVP, Regulatory AffairsReveal Email/Phone
3
EVP and COOReveal Email/Phone
4
SVP Human ResourcesReveal Email/Phone
5
VP ManufacturingReveal Email/Phone
6
SVPReveal Email/Phone
7
Head Pharmaceutical DevelopmentReveal Email/Phone
8
EVP, General Counsel and Chief Strategy OfficeReveal Email/Phone
9
SVP, Regulatory AffairsReveal Email/Phone
10
SVP Human ResourcesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is Genprex?

Genprex (Nasdaq: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches for patients with cancer and other serious diseases.

keywords:N/A

N/A

Total Funding

35

Number of Employees

$5.4M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Genprex News

2022-04-13 - Genprex to Participate in Upcoming Investor and Industry Conferences in April 2022

Genprex's oncology program utilizes its unique, proprietary, non-viral ONCOPREX® Nanoparticle Delivery System, which the Company believes is the...

2022-03-30 - Genprex pairs gene therapy delivery tech with Keytruda in ...

Genprex has begun testing a drug candidate based on its systemic gene therapy delivery platform in combination with Merck's Keytruda.

2022-03-22 - Genprex Announces the Opening for Enrollment of its Phase 1 ...

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.1M3530%N/A
#2
$9.2M35-15%N/A
#3
$3.9M35N/AN/A
#4
$4.1M35N/AN/A
#5
$4.1M35N/AN/A